Harbor Health vs ArteraAI
A side-by-side comparison built from both listings. Blank cells mean the company has not given that detail; we never guess.
Harbor Health compared with ArteraAI
| Detail | 
Harbor Health | 
ArteraAI |
|---|
| What it does | Weight loss, with an end in sight
| Personalized precision medicine powered by AI for cancer therapy
|
|---|
| Stage | Startup
| Not given
|
|---|
| Founded | 2026
| Not given
|
|---|
| Based in | US
| US
|
|---|
| Pricing model | Paid
| Contact for pricing
|
|---|
| Pricing | Harbor Steady (semaglutide): $99/month; Harbor Accelerate (tirzepatide): $149/month. No price increases, no hidden fees, HSA/FSA eligible.
| Not given
|
|---|
| Key features | - Physician-reviewed prescriptions with same-day approval
- Free and discreet 48-hour FedEx Express shipping
- 24/7 physician access through patient portal
- Board-certified U.S. physicians specializing in weight management
- Personalized dietitian support for post-treatment maintenance
- Compounded medications from certified U.S. pharmacies
| - Analyzes digital pathology with no additional tissue staining required
- Rapid results within 1-2 days after specimen receipt
- Validated across diverse populations including African American and non-African American men
- FDA De Novo authorization for prostate cancer risk stratification
- Insurance coverage for Medicare and many commercial plans
- Provides 5 and 10-year distant metastasis risk for breast cancer
- Identifies breast cancer patients who benefit from chemotherapy
- Included in NCCN Clinical Practice Guidelines for Prostate Cancer
|
|---|
| What makes it different | - Only GLP-1 program that guarantees results with 12-month refund policy
- Includes registered dietitian support post-treatment to maintain weight loss
- Locked pricing with no increases as dosage changes
- Personalized treatment plans from board-certified obesity medicine specialists
- 48-hour medication delivery after approval
| - No additional tissue preparation needed, uses existing H&E slides
- Validated across multiple large randomized phase III clinical trials
- FDA De Novo clearance as Software as a Medical Device
- Financial assistance program to make tests affordable regardless of income
|
|---|
| Community votes | 0 | 0 |
|---|
| DR (Domain Rating by Ahrefs) | 21 ▼ −1 (down) since last check | 57 ● no change since last check |
|---|
| Trust Flow (Majestic) | 5 | 15 |
|---|
| Citation Flow (Majestic) | 21 | 27 |
|---|
| Referring domains (Majestic) | 33 | 285 |
|---|
5 details filled in for both companies.
More alternatives to Harbor Health More alternatives to ArteraAI